{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:24:18Z","timestamp":1788668658251,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.prnil.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T03:15:00Z","timestamp":1742872500000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multimodality focal therapy for prostate cancer: outcome of the \u00e0 la carte approach in clinical practice"],"prefix":"10.1016","volume":"13","author":[{"given":"Chi-Hang","family":"Yee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K-F.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Q.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson H.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen CM.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.Y.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Y.C.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prnil.2025.03.006_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eururo.2021.10.005","article-title":"Focal Therapy for Prostate Cancer: Getting Ready for Prime Time","volume":"81","author":"Abreu","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2025.03.006_bib2","article-title":"Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?-a systematic review and meta-analysis","author":"Tay","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.prnil.2025.03.006_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.eururo.2015.12.015","article-title":"Focal Therapy for Prostate Cancer: An \"A la Carte\" Approach","volume":"69","author":"Sivaraman","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2025.03.006_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7157973","article-title":"High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform","volume":"2021","author":"Yee","year":"2021","journal-title":"Adv Urol"},{"issue":"5","key":"10.1016\/j.prnil.2025.03.006_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bju.16690","article-title":"Cryotherapy for posterior lesions of the prostate: the hydrogel technique","volume":"135","author":"Yee","year":"2025","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.prnil.2025.03.006_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41391-022-00577-8","article-title":"Transperineal Targeted Microwave Ablation (TMA) of localized prostate cancer guided by MRI-Ultrasound fusion and organ-based tracking: a pilot study","volume":"26","author":"Chiu","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2025.03.006_bib7","article-title":"Biopsy strategies in the era of mpMRI: a comprehensive review","author":"Windisch","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.prnil.2025.03.006_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41391-018-0042-0","article-title":"Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement","volume":"21","author":"Ganzer","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.prnil.2025.03.006_bib9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00345-020-03297-7","article-title":"Focal HIFU therapy for anterior compared to posterior prostate cancer lesions","volume":"39","author":"Huber","year":"2021","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.prnil.2025.03.006_bib10","doi-asserted-by":"crossref","first-page":"30 e9","DOI":"10.1016\/j.urolonc.2016.07.015","article-title":"Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer","volume":"35","author":"Dickinson","year":"2017","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.prnil.2025.03.006_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.prnil.2022.12.004","article-title":"Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis","volume":"11","author":"Ahn","year":"2023","journal-title":"Prostate Int"},{"issue":"3","key":"10.1016\/j.prnil.2025.03.006_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/bco2.62","article-title":"The diagnostic accuracy of multiparametric MRI for detection and localization of prostate cancer depends on the affected region","volume":"2","author":"Martins","year":"2021","journal-title":"BJUI Compass"},{"issue":"10","key":"10.1016\/j.prnil.2025.03.006_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-Targeted or Standard Biopsy in Prostate Cancer Screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.prnil.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.prnil.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euo.2023.04.007","article-title":"Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy","volume":"6","author":"Giganti","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.prnil.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2024.02.001","article-title":"The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations","volume":"85","author":"Light","year":"2024","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.prnil.2025.03.006_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4111\/icu.20230435","article-title":"Applications of artificial intelligence in urologic oncology","volume":"65","author":"Pak","year":"2024","journal-title":"Investig Clin Urol"},{"issue":"3","key":"10.1016\/j.prnil.2025.03.006_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eururo.2024.02.003","article-title":"Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?","volume":"86","author":"Baboudjian","year":"2024","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2025.03.006_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/end.2009.0596","article-title":"Focal therapy in prostate cancer-report from a consensus panel","volume":"24","author":"de la Rosette","year":"2010","journal-title":"J Endourol"},{"issue":"3","key":"10.1016\/j.prnil.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/pcan.2017.8","article-title":"Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project","volume":"20","author":"Tay","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"10","key":"10.1016\/j.prnil.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00345-019-02636-7","article-title":"Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project","volume":"37","author":"van Luijtelaar","year":"2019","journal-title":"World J Urol"},{"issue":"11","key":"10.1016\/j.prnil.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"781 e17","DOI":"10.1016\/j.urolonc.2021.01.027","article-title":"Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus","volume":"39","author":"Tan","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.prnil.2025.03.006_bib23","article-title":"Identifying the best candidate for focal therapy: a comprehensive review","author":"Ghoreifi","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.prnil.2025.03.006_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.eururo.2020.05.018","article-title":"Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus","volume":"78","author":"Lebastchi","year":"2020","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.prnil.2025.03.006_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4081\/aiua.2022.4.413","article-title":"Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience","volume":"94","author":"Dias","year":"2022","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.prnil.2025.03.006_bib26","article-title":"Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)","author":"Nicoletti","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.prnil.2025.03.006_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prnil.2024.03.004","article-title":"Propensity score matched analysis of functional outcome in five thousand cases of robot-assisted radical prostatectomy versus high-intensity focused ultrasound","volume":"12","author":"Nam","year":"2024","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2025.03.006_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/462153","article-title":"Urodynamic evaluation after high-intensity focused ultrasound for patients with prostate cancer","volume":"2014","author":"Mearini","year":"2014","journal-title":"Prostate Cancer."}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:25:44Z","timestamp":1765434344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888225000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2287888225000406"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2025.03.006","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality focal therapy for prostate cancer: outcome of the \u00e0 la carte approach in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}